Edwards Lifesciences Corp (EW) financials · P/E 50, rev $6.07B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Edwards Lifesciences Corp (EW) P/E 50, rev $6.07B.
| Line | FY2025 | FY2023 |
|---|---|---|
| Revenue | $6.07B | $6.00B |
| Cost of Revenue | $1.33B | $1.38B |
| Gross Profit | $4.73B | $4.63B |
| Operating Income | $1.26B | $1.53B |
| Net Income | $1.07B | $1.40B |
| EPS (Diluted) | $1.83 | $2.30 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $13.70B | $13.06B |
| Current Assets | $6.74B | $6.29B |
| Cash & Equivalents | $2.94B | $3.05B |
| Inventory | $1.13B | $1.09B |
| PP&E | $1.81B | $1.69B |
| Total Liabilities | $3.36B | $2.99B |
| Current Liabilities | $1.81B | $1.51B |
| Long-term Debt | $598.3M | $597.7M |
| Total Debt | $598.3M† | $597.7M† |
| Shareholders' Equity | $10.34B | $10.00B |
| Retained Earnings | $14.24B | $13.17B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $1.60B | $542.3M |
| CapEx | $260.2M | $252.4M |
| Investing Cash Flow | -$712.9M | $2.31B |
| Financing Cash Flow | -$956.8M | -$983.0M |
| Net Change in Cash | -$119.3M | $1.91B |
| Free Cash Flow | $1.33B | $289.9M |
FAQ
What is EW P/E and revenue?
Edwards Lifesciences Corp (EW) P/E 50, rev $6.07B.
What is EW revenue?
Edwards Lifesciences Corp last cached revenue is $6.07B (FY2025).
Is EW profitable?
Edwards Lifesciences Corp last cached net income is $1.07B (FY2025).
What are EW total assets?
Edwards Lifesciences Corp last cached total assets are $13.70B (FY2025).
What is EW free cash flow?
Edwards Lifesciences Corp last cached free cash flow is $1.33B (FY2025).
Not investment advice. Cached statements, not a live tape.